LONDON (AP) — The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint ...
Ending a monthslong auction process, drug giant GlaxoSmithKline has begun exclusive negotiations to sell its nutrition business to consumer goods company Unilever, according to The Financial Times. 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results